Endothelial dysfunction and persistent inflammation in severe post-COVID-19 patients: implications for gas exchange

Area of Science:

• Pulmonology
• Immunology
• Critical Care Medicine

Background:

• Severe COVID-19 can lead to long-term respiratory complications.
• Understanding post-COVID conditions is vital for managing severe acute respiratory distress syndrome (ARDS) survivors.

Purpose of the Study:

• To evaluate the impact of post-COVID conditions on respiratory sequelae in severe ARDS survivors.
• To identify biomarkers associated with persistent respiratory dysfunction after severe COVID-19.

Main Methods:

• Assessed 88 COVID-19-associated severe ARDS survivors six months post-ICU discharge.
• Measured clinical, functional, and plasma biomarkers (endothelial dysfunction, inflammation, viral response).
• Utilized an in vitro model with human umbilical vein endothelial cells (HUVECs) to assess plasma effects.

Main Results:

• Impaired gas exchange correlated with elevated endothelial inflammation biomarkers (ICAM-1, IL-8, CCL-2, ET-1).
• Systemic inflammation (NLRP3, IL-6, sCD40-L, CRP) and T-cell activation (CD69, IFN-β) were linked to endothelial dysfunction.
• In vitro models confirmed post-COVID plasma alters endothelial function.

Conclusions:

• COVID-19 ARDS survivors show sustained endothelial dysfunction biomarkers six months post-ICU.
• Ongoing inflammation from NLRP3 inflammasome activity and T-cell activation contributes to persistent endothelial dysfunction.
• Sustained viral immune response may intensify endothelial dysfunction in post-COVID patients.